Duncan W, Catton C N, Warde P, Gospodarowicz M K, Munro A J, Lakier R, Simm J, Panzarella T
Department of Clinical Oncology, University of Edinburgh, Western General Hospital, UK.
Radiother Oncol. 1994 Apr;31(1):41-50. doi: 10.1016/0167-8140(94)90412-x.
Results of 999 patients with carcinoma of the prostate treated with radical radiotherapy were evaluated to assess the impact of pre-treatment transurethral resection of the prostate. (TURP). A total of 427 patients had a needle biopsy and 541 patients had a TURP. In 31 patients the diagnostic procedure could not be ascertained. In patients with stage T1/T2 disease (411) no adverse effect on prognosis was observed following TURP compared with needle biopsy. In patients with stage T3/T4 disease (534) a significantly higher distant relapse rate and cause-specific mortality were observed after TURP but overall survival was similar after TURP and needle biopsy. A significant correlation was observed between the probability of TURP and poorly differentiated cancers. Multivariate analysis which evaluated the influence of age, T stage, histologic differentiation and TURP did not demonstrate diagnostic TURP to be a significant independent prognostic variate for patients with prostate cancer managed by radical radiotherapy.
对999例接受根治性放疗的前列腺癌患者的结果进行评估,以评估治疗前经尿道前列腺切除术(TURP)的影响。共有427例患者进行了穿刺活检,541例患者进行了TURP。31例患者的诊断程序无法确定。在T1/T2期疾病患者(411例)中,与穿刺活检相比,TURP后未观察到对预后有不良影响。在T3/T4期疾病患者(534例)中,TURP后观察到远处复发率和特定病因死亡率显著更高,但TURP和穿刺活检后的总生存率相似。TURP的可能性与低分化癌之间存在显著相关性。评估年龄、T分期、组织学分化和TURP影响的多变量分析未显示诊断性TURP是接受根治性放疗的前列腺癌患者的显著独立预后变量。